Navigation Links
Cannabis use mimics cognitive weakness that can lead to schizophrenia
Date:11/2/2012

Researchers at the University of Bergen in Norway have found new support for their theory that cannabis use causes a temporary cognitive breakdown in non-psychotic individuals, leading to long-term psychosis. In an fMRI study published this week in Frontiers in Psychiatry, researchers found a different brain activity pattern in schizophrenia patients with previous cannabis use than in schizophrenic patients without prior cannabis use.

The results reinforce the researchers' model where cannabis users suffering from schizophrenia actually may have higher cognitive abilities than non-cannabis using schizophrenics. This difference may indicate that the cannabis-user group did not have the same mental propensity for psychosis.

"While brain activity for both groups was similar, there are subtle differences between schizophrenia sufferers with a history of cannabis use and those who have never used cannabis. These differences lead us to believe that the cognitive weakness leading to schizophrenia is imitated by the effects of cannabis in otherwise non-psychotic people," explains Else-Marie Loeberg, lead author on the article and associate professor of Psychology at the University of Bergen, Norway.

The 26 patients involved in the study attempted difficult cognitive tasks while in the fMRI machine. They were asked to listen to different syllables in each ear and try to say which syllable was spoken when instructed to concentrate on either the left or right eara difficult task for anyone but particularly difficult for schizophrenia patients who often have impaired attention, limited executive functioning and difficulty in processing verbal cues.

The study shows that schizophrenia sufferers with previous cannabis use had consistently higher levels of brain activity while undergoing these tests as well as a higher number of correct answers. These results are in line with previous conclusions from the Bergen researchers who support the idea that cannabis users with schizophrenic characteristics do not appear to suffer from the same neuro-cognitive weaknesses as other patients with schizophrenia.

This implies that it is the cannabis use itself that leads otherwise non-psychotic individuals down the nightmarish path towards schizophrenia by imitating the cognitive weakness that is the main risk factor for developing the psychological condition.


'/>"/>

Contact: Michael Mitchell
michael.mitchell@frontiersin.org
41-798-103-107
Frontiers
Source:Eurekalert

Related biology news :

1. U of S researchers discover cannabis pharma factory
2. To drive infections, a hijacking virus mimics a cells signaling system
3. Researchers develop ginseng-fortified milk to improve cognitive function
4. Piglets in mazes provide insights into human cognitive development
5. LSUHSC research finds ginkgo biloba doesn’t improve cognitive function in MS
6. Brain training may lessen cognitive impairments associated with coronary bypass surgery
7. Evolving to fight epidemics: Weakness can be an advantage
8. Weakness can be an advantage in surviving deadly parasites, a new study shows
9. The music of the (hemi)spheres sheds new light on schizophrenia
10. Johns Hopkins researchers link 2 biological risk factors for schizophrenia
11. Researchers pursue red flag for schizophrenia relapse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
Breaking Biology News(10 mins):
(Date:6/16/2017)... Lexington, Massachusetts (PRWEB) , ... June 16, 2017 ... ... in medical device compliance and commercialization, has just announced two more sessions of ... of the series will focus on the world of online templates for design ...
(Date:6/16/2017)... CT (PRWEB) , ... June 16, 2017 , ... ... night’s Entrepreneur Innovation Awards (EIA), held at The LOFT at Chelsea Piers in Stamford. ... project ideas to a panel of judges for an opportunity to secure $10,000 awards ...
(Date:6/15/2017)... ... June 15, 2017 , ... Cybrexa Therapeutics, a ... round of financing in the amount of $6 million. An investment vehicle affiliated ... the round. , The Series B funding will enable Cybrexa to complete the ...
(Date:6/15/2017)... (PRWEB) , ... June 15, 2017 , ... ... Saranas, a promising new medical device startup. Dan Parsley, angelMD’s SVP of Corporate ... angelMD members, and this angelMD syndicate is part of Saranas’ recently announced $4 ...
Breaking Biology Technology: